maybe read the company reports.
timeline for resubmission was given as previous quarter. delay is due to supply issues for assay validation kits needed for resubmission, which they now have in stock. subsequently the guidance for resubmission has moved to this quarter.
also msb believes the fda is in agreement that further trial evidence for gvhd is no longer required before resubmission.
maybe read the company reports. timeline for resubmission was...
-
- There are more pages in this discussion • 195 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
-0.020(1.83%) |
Mkt cap ! $1.230B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.09 | $1.07 | $1.255M | 1.162M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 123103 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 80222 | 11 |
View Market Depth
| Last trade - 11.06am 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |